|
Report Date : |
17.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
INTERNATIONAL PHARMA LABS (IPL) |
|
|
|
|
Registered Office : |
116-Zulqernain Chamber, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
August, 2005 |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Manufacturing of Veterinary Pharmaceutical Products |
|
|
|
|
No. of Employees : |
6 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Pakistan |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PAKISTAN - ECONOMIC
OVERVIEW
Decades of internal political disputes and low levels of foreign investment have led to slow growth and underdevelopment in Pakistan. Agriculture accounts for more than one-fifth of output and two-fifths of employment. Textiles account for most of Pakistan's export earnings, and Pakistan's failure to expand a viable export base for other manufactures has left the country vulnerable to shifts in world demand. Official unemployment is under 6%, but this fails to capture the true picture, because much of the economy is informal and underemployment remains high. Over the past few years, low growth and high inflation, led by a spurt in food prices, have increased the amount of poverty - the UN Human Development Report estimated poverty in 2011 at almost 50% of the population. Inflation has worsened the situation, climbing from 7.7% in 2007 to almost 12% for 2011, before declining to 10% in 2012. As a result of political and economic instability, the Pakistani rupee has depreciated more than 40% since 2007. The government agreed to an International Monetary Fund Standby Arrangement in November 2008 in response to a balance of payments crisis. Although the economy has stabilized since the crisis, it has failed to recover. Foreign investment has not returned, due to investor concerns related to governance, energy, security, and a slow-down in the global economy. Remittances from overseas workers, averaging about $1 billion a month since March 2011, remain a bright spot for Pakistan. However, after a small current account surplus in fiscal year 2011 (July 2010/June 2011), Pakistan's current account turned to deficit in fiscal year 2012, spurred by higher prices for imported oil and lower prices for exported cotton. Pakistan remains stuck in a low-income, low-growth trap, with growth averaging about 3% per year from 2008 to 2012. Pakistan must address long standing issues related to government revenues and energy production in order to spur the amount of economic growth that will be necessary to employ its growing and rapidly urbanizing population, more than half of which is under 22. Other long term challenges include expanding investment in education and healthcare, adapting to the effects of climate change and natural disasters, and reducing dependence on foreign donors.
|
Source
: CIA |
INTERNATIONAL PHARMA LABS (IPL)
|
Business Name |
INTERNATIONAL PHARMA LABS (IPL) |
|
Address |
Head Office / Registered Office: 116-Zulqernain Chamber, Ganpat Road, Lahore, Punjab-Pakistan. Factory Address: Raiwind road, Bhoptain Chowk, Defence road, 1 km
towards Kahna, Lahore, Punjab- Pakistan |
|
Telephone |
+92-42-37323037 +92-42-37354231 |
|
Fax |
+92 – 42 – 37233457 |
|
Mobile |
+92 – 332 –
4446687 Mr. Gohar Abbas Jawa |
|
Email |
|
|
Website |
|
|
Business activities |
Manufacturing of Veterinary Pharmaceutical Products |
Registry Details
IPL is a Proprietorship concern, registration with any regulatory body
is not mandatory.
|
CRO Registration Number |
N/A |
|
Date of Registration |
Other registry & certification details:
|
Current Legal Form |
Sole Proprietorship |
|
National Tax Registration Number |
Not Disclosed |
|
Date of Registration |
N/A |
|
GST Registration Number |
Not Disclosed |
|
Date of Registration |
N/A |
|
Chamber of Commerce & Industry |
The Lahore Chamber of Commerce & Industry |
|
Date of Registration |
Undetermined |
|
ISO Certification |
None |
|
Date of Registration |
N/A |
|
Other certifications |
Undetermined |
|
Date of Registration |
N/A |
History
|
Who started |
Sh. Ali Akbar Jawa |
|
When started |
August 2005 |
|
Change in management |
None |
|
Year of change |
N/A |
|
Change in legal status |
None |
|
Year of change |
N/A |
|
Change in business name |
None |
|
Year of change |
N/A |
|
Name |
Number of Shares |
Nationality |
Appointment Date
(Last) |
|
Sh. Ali Akbar Jawa |
100% |
Pakistani |
Not Disclosed |
|
Name |
Position in organization |
Qualification |
Years in
employment |
|
Gohar Jawa |
Manager |
Not Disclosed |
Not Disclosed |
|
Statutory offices |
|
|
Statutory Auditors |
Not Disclosed |
|
Legal Advisory Services |
Not Disclosed |
|
Bank name |
Approved
financing limits |
|
Soneri Bank Ltd. |
Depository Relation |
The primary focus of the concern is manufacturing of Veterinary
Medicines which is imported in different parts of the world including Asia,
Europe and Russia. Some of its products include:
Product's
Categories
·
Nutritional
water soluble powders
·
Medicinal
water soluble powders
·
Bolus
Product's Type
·
Antibiotics
(Non penicillins)
·
Hormones
·
Minerals
·
Vitamins
Purchases (Incl.
Imports)
|
Imports from |
Not Disclosed |
|
Importing terms |
|
|
Local (%) |
|
|
Local buying terms |
Sales (Incl.
Exports)
|
Exports to |
Not Disclosed |
|
Exporting terms |
|
|
Local (%) |
|
|
Local selling terms |
|
Nature of
employment |
Current Year |
Previous Year |
|
All Staff |
6 |
6 |
|
Total |
6 |
6 |
|
Head office Address Owned / Rented Area (approx) |
116-Zulqernain Chamber, Ganpat Road, Lahore, Punjab-Pakistan. Details not provided. |
|
Factory Address Owned / Rented Area (approx) |
Raiwind road, Bhoptain Chowk, Defence road, 1 km towards Kahna, Lahore,
Punjab- Pakistan 18000sq ft area Details not provided |
|
Warehouse Address Owned / Rented Area (approx) |
None
|
During the market check of the subject company we came to know that the
subject company belongs to ‘Jawa Group’
which is known as leading manufacturer of pharmaceutical products and well
known as profitable business in the industry.
IPL is not very well known in the market but the group is quite known in
the same industry. During market check we observed that companies gave a very
good response of the JAWA group but knew little about IPL. No complaints or
disputes were reported during the market check.
|
Business Name |
City |
Line of Business |
Percentile of
Shareholding |
|
Wilshire Labs.(Pvt) Ltd. |
LAHORE |
Pharmaceutical Medicines |
NOT PROVIDED |
|
Jawa Pharma (Pvt) Ltd) |
LAHORE |
Pharmaceutical Medicines |
NOT PROVIDED |
|
Irza Pharma |
LAHORE |
Pharmaceutical Medicines |
NOT PROVIDED |
The Contact person decline to share financial information.
|
Contact person |
Mr. Gohar Abbas Jawa |
|
Position |
Manager |
|
Comments |
We visited the said business premises, the contact person confirmed
business operations but declined to provide any further information. |
|
Analyst Observations |
The company office is quite well build and suitable for this kind of
business. The contact person was very reluctant to disclose the details of the
company. He declined to disclose the financial information. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.10 |
|
|
1 |
Rs.101.27 |
|
Euro |
1 |
Rs.85.43 |
INFORMATION DETAILS
|
Report Prepared
by : |
NNA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.